Longevity Health Statistics Share Statistics Longevity Health has 1.48M
shares outstanding. The number of shares has increased by -0.01%
in one year.
Shares Outstanding 1.48M Shares Change (YoY) -0.01% Shares Change (QoQ) 0.01% Owned by Institutions (%) 0.17% Shares Floating 927.22K Failed to Deliver (FTD) Shares 8,534 FTD / Avg. Volume 0.38%
Short Selling Information The latest short interest is 141.56K, so 9.54% of the outstanding
shares have been sold short.
Short Interest 141.56K Short % of Shares Out 9.54% Short % of Float 11.86% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -16.88 and the forward
PE ratio is null.
Longevity Health's PEG ratio is
0.52.
PE Ratio -16.88 Forward PE n/a PS Ratio 3477.45 Forward PS n/a PB Ratio -37.13 P/FCF Ratio -39.87 PEG Ratio 0.52
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Longevity Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.16,
with a Debt / Equity ratio of -0.14.
Current Ratio 0.16 Quick Ratio 0.14 Debt / Equity -0.14 Debt / EBITDA -0.06 Debt / FCF -0.15 Interest Coverage -101.98
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $3.35K Profits Per Employee $-691.22K Employee Count 15 Asset Turnover 0.03 Inventory Turnover 0.06
Taxes Income Tax -97.28K Effective Tax Rate 0.91%
Stock Price Statistics The stock price has increased by -91.47% in the
last 52 weeks. The beta is 0.51, so Longevity Health's
price volatility has been higher than the market average.
Beta 0.51 52-Week Price Change -91.47% 50-Day Moving Average 3.06 200-Day Moving Average 6.68 Relative Strength Index (RSI) 41.47 Average Volume (20 Days) 2,235,840
Income Statement In the last 12 months, Longevity Health had revenue of 50.32K
and earned -10.37M
in profits. Earnings per share was -0.5.
Revenue 50.32K Gross Profit 43.96K Operating Income -5M Net Income -10.37M EBITDA -10.5M EBIT -10.7M Earnings Per Share (EPS) -0.5
Full Income Statement Balance Sheet The company has 157.14K in cash and 638.99K in
debt, giving a net cash position of -481.85K.
Cash & Cash Equivalents 157.14K Total Debt 638.99K Net Cash -481.85K Retained Earnings -68.87M Total Assets 3.34M Working Capital -3.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.39M
and capital expenditures 0, giving a free cash flow of -4.39M.
Operating Cash Flow -4.39M Capital Expenditures n/a Free Cash Flow -4.39M FCF Per Share -0.21
Full Cash Flow Statement Margins Gross margin is 87.37%, with operating and profit margins of -9933.82% and -20605.47%.
Gross Margin 87.37% Operating Margin -9933.82% Pretax Margin -21359.64% Profit Margin -20605.47% EBITDA Margin -20870.2% EBIT Margin -9933.82% FCF Margin -8722.42%
Dividends & Yields XAGE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for XAGE.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 14, 2025. It was a
backward
split with a ratio of 1:30.
Last Split Date May 14, 2025 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -38.96 Piotroski F-Score 4
